Scott B. Capps, VP, Clinical Research at CRYOLIFE INC (CRY), sold 16,732 shares at $21.34 ($357K) on 2020-12-15, disclosed to the SEC on 2020-12-16.
Open-market sale of $357k CRY by VP, Clinical Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.34 | 8,366 | $179K | 50.0% |
| 2 | $21.34 | 8,366 | $179K | 50.0% |
| Total | $21.34 avg | 16,732 | $357K | 100% |
| Filing → |
| CRY | SELL | 2018-09-04 | $432K | — | Filing → |
| CRY | SELL | 2017-02-24 | $364K | — | Filing → |
| CRY | SELL | 2016-02-23 | $155K | — | Filing → |